FDAnews Drug Daily Bulletin

VANDA PHARMACEUTICALS DEBUTS ON NASDAQ

April 14, 2006
A A

Vanda Pharmaceuticals began trading on the Nasdaq Wednesday. Stock in the Rockville-based developer of psychiatric drugs was trading at about $9.30 a share by noon. Vanda priced its IPO at $10 per share, offering 5.75 million shares to the public and a 30-day option by its underwriters to purchase an additional 862,500 shares.
Washington Business Journal